Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

India Bans 344 'Irrational' Fixed Dose Drugs; Next Round In Court

This article was originally published in SRA

Executive Summary

The Indian government has banned 344 drugs - specifically, fixed dose combinations (FDCs) – on the ground that these products had "no therapeutic justification" and could pose risks to human health1. Some of the banned drugs had been available on the market for several years.